Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms.
Kubo K, Ohara M, Tachikawa M, Cavallari LH, Lee MTM, Wen MS, Scordo MG, Nutescu EA, Perera MA, Miyajima A, Kaneko N, Pengo V, Padrini R, Chen YT, Takahashi H. Kubo K, et al. Among authors: takahashi h. Pharmacogenomics J. 2017 Dec;17(6):494-500. doi: 10.1038/tpj.2016.57. Epub 2016 Aug 9. Pharmacogenomics J. 2017. PMID: 27503578
DPP6 as a candidate gene for neuroleptic-induced tardive dyskinesia.
Tanaka S, Syu A, Ishiguro H, Inada T, Horiuchi Y, Ishikawa M, Koga M, Noguchi E, Ozaki N, Someya T, Kakita A, Takahashi H, Nawa H, Arinami T. Tanaka S, et al. Among authors: takahashi h. Pharmacogenomics J. 2013 Feb;13(1):27-34. doi: 10.1038/tpj.2011.36. Epub 2011 Aug 9. Pharmacogenomics J. 2013. PMID: 21826085
Population pharmacokinetics and pharmacodynamics of cisplatin in patients with cancer: analysis with the NONMEM program.
Nagai N, Ogata H, Wada Y, Tsujino D, Someya K, Ohno T, Masuhara K, Tanaka Y, Takahashi H, Nagai H, Kato K, Koshiba Y, Igarashi T, Yokoyama A, Kinameri K, Kato T, Kurita Y. Nagai N, et al. Among authors: takahashi h. J Clin Pharmacol. 1998 Nov;38(11):1025-34. doi: 10.1177/009127009803801107. J Clin Pharmacol. 1998. PMID: 9824784 Clinical Trial.
Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes.
Takahashi H, Kashima T, Nomoto S, Iwade K, Tainaka H, Shimizu T, Nomizo Y, Muramoto N, Kimura S, Echizen H. Takahashi H, et al. Pharmacogenetics. 1998 Oct;8(5):365-73. doi: 10.1097/00008571-199810000-00001. Pharmacogenetics. 1998. PMID: 9825828
14,450 results
You have reached the last available page of results. Please see the User Guide for more information.